GLAXOSMITHKLINE PLC
GLAXF
|
$20.2
510
|
Health Technology
(0.0% 1d) (-3.6% 1m) (3.4% 1y) (0.0% 2d) (0.0% 3d) (-1.5% 7d) (-50.0% volume)
Earnings Calendar:
Market Cap: $ 83,933,818,910
http://gsk.com
Sec Filling | Patents | n/a employees
(GB) GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
brands hepatitis infectious disease respiratory vaccine battery batteries pain relief gastrointestinal skin pets influenza
add to watch list Paper trade email alert is off
Press-releases
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.15 -1.5% 2.3M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
PHG | $20.28 -0.64% 260K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
VRNA | $16.02 1.39% 270K
|
Health Technology
|
| O: 1.27%
H: 0.0%
C: 0.0%
reach treatment research market
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
AZN | $68.38 -0.51% 2.1M
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
set therapeutics market
Antacids Market Projected to Reach $10.18 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-05 (Crawled : 15:00) - prnewswire.com
RBGPF | $51.8 8K
|
Consumer Non-Durables
|
| O: 2.8%
H: 0.0%
C: -4.35%
GLAXF | $20.2 510
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNYNF | $92.966 630
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
RBGLY | $10.49 5.1M
|
Manufacturing
|
| O: -0.84%
H: 0.09%
C: -0.09%
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: -0.66%
H: 1.63%
C: 1.48%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
report reach market
Mouthwash Market size to grow by USD 2.08 billion from 2022 to 2027, Technavio
Published: 2024-04-01 (Crawled : 14:30) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: -6.16%
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: -0.3%
H: 0.3%
C: -0.75%
market
Global Infectious Enteritis Treatment Market Report 2024: A USD$937.7 Million Market by 2034 - Antibiotics Segment Dominates the Market
Published: 2024-03-29 (Crawled : 23:00) - prnewswire.com
ARDX | $6.83 0.44% 2.3M
|
Health Technology
| Email alert
Add to watchlist
SNY | $46.19 0.57% 580K
|
Health Technology
| Email alert
Add to watchlist
ABT | $109.92 0.95% 3.2M
|
Health Technology
| Email alert
Add to watchlist
GSK | $40.035 -1.15% 1.5M
|
Health Technology
| Email alert
Add to watchlist
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $92.966 630
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 510
|
Health Technology
| Email alert
Add to watchlist
report million treatment antibiotics global market
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
AMGN | $264.955 -0.21% 880K
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
antibody research global
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
SNYNF | $92.966 630
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
AZNCF | $135.94 770
|
Health Technology
|
| O: 0.89%
H: 0.78%
C: 0.78%
NVSEF | $93.6375 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 0.36%
H: 0.72%
C: 0.61%
ABT | $109.92 0.95% 3.2M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
AZN | $68.38 -0.51% 2.1M
|
Health Technology
|
| O: -0.12%
H: 0.25%
C: -0.63%
AMGN | $264.955 -0.21% 880K
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
abbvie set canada key market
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-03-22 (Crawled : 04:00) - prnewswire.com
ALPMF | $9.48 1.7K
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: 0.0%
GLAXF | $20.2 510
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
AZNCF | $135.94 770
|
Health Technology
|
| O: 2.67%
H: 0.0%
C: -1.58%
ALPMY | $9.2715 500K
|
Manufacturing
|
| O: 2.26%
H: 0.0%
C: -2.65%
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: 0.4%
H: 0.33%
C: -0.45%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
AZN | $68.38 -0.51% 2.1M
|
Health Technology
|
| O: 0.45%
H: 0.53%
C: -0.35%
market
Iron Drugs Market size to grow by USD 3.55 billion from 2022 to 2027, Technavio
Published: 2024-03-22 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
SNYNF | $92.966 630
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: 0.4%
H: 0.33%
C: -0.45%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
ABT | $109.92 0.95% 3.2M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
market
Medical Grade Skincare Market Projected to Reach $168.06 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-03-13 (Crawled : 14:30) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -0.29%
H: 3.03%
C: 3.03%
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: 0.0%
H: 0.23%
C: 0.21%
report reach medical market
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 53% | 47% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
Last 48 Hours Insiders Buying
RVP P 3587 | $1.06 -1.85% 21K
|
Health Technology
|
17:00
TPL P 12 | $588.26 0.75% 12K
|
Miscellaneous
|
16:01
HNRA | $2.617 10.89% 260K
|
n/a
|
15:02
TGEN | $0.67 16K
|
Utilities
|
14:30
RMCF | $3.6492 9.1K
|
Consumer Non-Durables
|
20:10